Our Recommendations
New Publications
- Suspension of supply of COVID-19 vaccine (COVAXIN®) (2022)
- Recomendaciones provisionales para el uso de la vacuna BBV152 COVAXIN® de Bharat Biotech contra la COVID-19: orientaciones provisionales, primera publicación: 3 de noviembre de 2021, actualización: 15 (2022)
- Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19 (2022)
- Covaxin (2021)
- COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine (2022)
Filter
6
Featured
New Publications
2
Language
Document type
Fact sheets
3
Guidelines
2
Studies & Reports
1
Countries / Regions
India
4
Authors & Publishers
Publication Years
Category
COVID-19
4
Toolboxes
Covaxin
6
Vaxzevria (Astra Zeneca)
1
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
2 April 2022
